# psoriasis - grok-4.6

- Benchmark system: E2seq + Agent RAG
- Repeat: 3
- Task type: DISEASE-STATE
- Tissue / sample source: lesional skin
- Comparison or endpoint: psoriatic lesional skin versus normal control skin
- Answer input cohort: Discovery/Core only
- Selected items: 100
- Input fields: gene name, effect size (log2FC/HR), P value, FDR
- E2seq Agent RAG: enabled
- Conversation memory: disabled
- Thinking mode: disabled
- Held-out validation data in prompt/RAG: no
- Model API: xAI / grok-4.6
- Message SHA-256: d1a33d3f606c81814c4fb94a6c63c8f1abebd3bde37d769e82eae4772d8ff873
- Response HTTP status: 200
- Prompt tokens: 53190
- Completion tokens: 13238
- Reasoning tokens: 6518
- Total tokens: 66428
- API requests reported: 4
- Elapsed seconds: 93.472
- RAG status: reused_or_ready
- RAG records/genes reported: 100
- RAG elapsed seconds: 1150.303
- Question handoff seconds: 1163.566
- Final benchmark system: E2seq; file rank 3/5; original repeat 3; model vendor: xAI

---
**1. Overall biological interpretation**  
The transcriptomic profile of psoriatic lesional skin versus normal control skin is dominated by strong upregulation (90 genes) of inflammatory, antimicrobial, and epidermal-remodeling programs, with only modest downregulation (10 genes). This pattern reflects the core molecular drivers of plaque formation: keratinocyte activation, IL-17/IL-36 axis engagement, antimicrobial peptide production, and cornified-envelope maturation. The data show coordinated activation of multiple independent gene sets rather than isolated gene changes, consistent with the known biology of psoriasis as a cytokine-driven, barrier-disrupted inflammatory disease of skin.

**2. Core biological programs**  
**Program 1: IL-36/IL-17 cytokine signaling**  
Direction: strongly upregulated  
Major supporting genes: IL36A, IL36G, IL36RN, IL19, IL20, IL26, IRAK2  
Standardized pathway: IL-17 signaling pathway (KEGG) and Cytokine-cytokine receptor interaction (KEGG)  
Explanation: These genes encode ligands, receptors, and downstream signaling components that are collectively highly upregulated; they drive NF-κB and MAPK activation in keratinocytes and immune cells, amplifying the IL-17/IL-36 loop that is central to psoriatic plaque initiation and maintenance.  
Strength of evidence and limitations: Multiple independent genes + direct GO/KEGG overlap; strong limitation is that this is a single-cohort snapshot with no independent replication statistics provided.

**Program 2: Antimicrobial humoral response**  
Direction: strongly upregulated  
Major supporting genes: DEFB4A, DEFB4B, DEFB103A, DEFB103B, S100A7, S100A8, S100A12  
Standardized pathway: Antimicrobial Humoral Response (GO:0019730)  
Explanation: Defensins and S100 proteins form a coordinated antimicrobial barrier that is massively induced in psoriatic epidermis, reflecting both direct keratinocyte antimicrobial activity and secondary recruitment of neutrophils.  
Strength of evidence and limitations: Multiple genes across GO terms; limitation is that defensin/S100 induction can be secondary to neutrophil infiltration rather than a primary keratinocyte program.

**Program 3: Epidermal hyperproliferation and cornified-envelope formation**  
Direction: strongly upregulated  
Major supporting genes: KRT6A, SPRR2A/B/D/E/F/G, LCE3A/D, SERPINB3/4  
Standardized pathway: Formation of the cornified envelope (R-HSA-6809371) and Epidermis Development (GO:0008544)  
Explanation: Keratin and filaggrin-associated genes are among the highest-ranked, indicating terminal differentiation arrest and thickened, parakeratotic stratum corneum that characterizes psoriatic plaques.  
Strength of evidence and limitations: Strong multi-gene signal with GO/Reactome support; limitation is that these changes reflect both keratinocyte-intrinsic reprogramming and secondary effects of immune-cell infiltration.

**Program 4: Chemotaxis and leukocyte recruitment**  
Direction: upregulated  
Major supporting genes: CXCL13, CXCR2, CCR6-linked genes, CD274  
Standardized pathway: Cytokine-cytokine receptor interaction (KEGG)  
Explanation: Chemotactic and chemokine-receptor genes enable immune-cell trafficking into the skin, sustaining the inflammatory infiltrate.  
Strength of evidence and limitations: Supported by STRING network edges and GO overlap; limitation is the absence of independent cohort statistics to confirm reproducibility.

**3. Key genes and interaction modules**  
- **IL36A** (log2FC 11.37, FDR 1.66e-98): central to Program 1; direct physical interaction with IL36RN and IL1RAP (STRING).  
- **IL36RN** (log2FC 3.01, FDR 3.85e-62): Program 1; regulatory antagonist of IL36A/IL36G signaling (STRING edges to IL1RAP, IL36B, IL36G).  
- **DEFB4A/DEFB4B** (log2FC ~11): Program 2; co-expressed with other defensins and S100 proteins (STRING).  
- **S100A7/A8/A12** (log2FC 7–9.8): Program 2; direct physical interactions among family members and with SERPINB3/4 (STRING).  
- **SPRR2A** (log2FC 7.312, FDR 2.933e-85): Program 3; extensive STRING co-expression and pathway co-membership within cornified-envelope module.  
- **KRT6A** (log2FC 4.30): Program 3; co-expressed with SPRR and LCE genes.  
- **CXCL13** (log2FC 5.89): Program 4; regulatory interaction with CXCR2 and CCR6 (STRING).  
- **IRAK2** (log2FC 2.08): Program 1; pathway co-membership with IL36 family in NF-κB signaling.

**4. Validation priorities**  
1. **Mechanistic hypothesis**: Functional validation of IL36RN as a modulator of IL36A/G activity in keratinocyte cultures. Why: multiple genes + STRING interactions in Program 1; dataset evidence: strong log2FC and FDR; external evidence: established IL-36/IL-17 axis in psoriasis; next step: CRISPR knockout or siRNA in primary keratinocytes; level: Supported hypothesis.  
2. **Biomarker**: Serum or skin mRNA levels of DEFB4A, S100A8, and SPRR2 genes for disease activity monitoring. Why: highest log2FC among antimicrobial and cornified-envelope genes; dataset evidence: extreme statistical significance; external evidence: literature supports defensin/S100 biomarkers; next step: longitudinal cohort study; level: Supported hypothesis.  
3. **Therapeutic target**: IL36A/IL36G as targets for IL-36 pathway blockade. Why: top-ranked upregulated genes in Program 1; dataset evidence: log2FC >11; external evidence: IL-36 inhibitors in clinical trials; next step: tissue-specific expression studies; level: Supported hypothesis.  
4. **Interaction/network hypothesis**: SPRR2 gene module as a downstream effector of IL-17 signaling. Why: STRING edges and GO overlap; dataset evidence: coordinated upregulation; external evidence: co-expression networks in psoriasis skin; next step: CRISPR perturbation of SPRR2 cluster; level: Exploratory hypothesis.  
5. **Confounding or composition check**: Skin-infiltrating neutrophil versus keratinocyte contribution to S100A8/A12 and defensin signals. Why: antimicrobial genes are partly neutrophil-derived; dataset evidence: strong upregulation but no cell-type resolution; external evidence: known neutrophil infiltration in psoriasis; next step: single-cell RNA-seq comparison; level: Exploratory hypothesis.

**5. Evidence grounding**  
- Programs are grounded in direct uploaded log2FC/P/FDR values (primary evidence) plus GO/KEGG/Reactome annotations (pathway evidence) and STRING co-expression edges (network evidence).  
- Key genes draw from the same direct statistical evidence; gene–gene relationships are classified as direct physical (STRING), regulatory (STRING), co-expression (STRING), or pathway co-membership (GO/KEGG).  
- All conclusions distinguish dataset statistics from external contextual evidence; no independent-cohort statistics are supplied, so replication statements are explicitly avoided. Literature records (PubMed/Europe PMC) support known psoriasis associations but are not used as primary statistical evidence.

**6. Limitations and alternative explanations**  
- Skin tissue is heterogeneous; keratinocyte vs. infiltrating immune-cell contributions cannot be disentangled without single-cell resolution.  
- No adjustment for disease severity, age, or sex is reported, so these may confound absolute expression levels.  
- Batch/platform effects are possible given the single-cohort design, though low FDR values reduce concern.  
- Downregulated genes (e.g., BTC, CYP2W1) may reflect secondary loss of epidermal homeostasis rather than primary protective programs.  
- Association-versus-causation ambiguity: strong statistical associations do not prove causality without functional perturbation experiments.

The provided transcriptomic data establish a robust, multi-program inflammatory and epidermal-remodeling signature that aligns with established psoriasis biology, yet single-cohort limitations necessitate functional and multi-omics validation to translate these findings into mechanistic insights or clinical applications.

E2seq statistical audit: selected=100, ledger=100, RAG records=100, numeric claims checked=10, external claims checked=0, external mismatches=0, status=passed.

Answer model API: xAI / grok-4.6

Source coverage (gene sources = selected items with records / selected RAG items; literature sources = articles / queries)
Online APIs: alliance 91/100 selected items (records returned); cbioportal 91/100 selected items (records returned); chembl 11/100 selected items (partially returned; some queries failed); civic 4/100 selected items (records returned); clinicaltrials 40/100 selected items (records returned); clinvar 90/100 selected items (records returned); ensembl 44/100 selected items (partially returned; some queries failed); europepmc 848 articles / initial full-cohort RAG 100 queries + 4 current-round queries; gtex 83/100 selected items (records returned); gwas 100/100 selected items (records returned); hpa 76/100 selected items (records returned); humanbase 100/100 selected items (records returned); intact 79/100 selected items (records returned); mygene 100/100 selected items (records returned); omnipath 36/100 selected items (records returned); opentargets 90/100 selected items (records returned); pubmed 669 articles / initial full-cohort RAG 100 queries + 3 current-round queries; quickgo 80/100 selected items (records returned); reactome 100/100 selected items (records returned); uniprot 80/100 selected items (records returned)
Local databases: gutmgene 2/100 selected items (records returned); hmdb 25/100 selected items (records returned); string 78/100 selected items (records returned); trrust 17/100 selected items (records returned)
